Search

Humana Inc

Geschlossen

BrancheGesundheitswesen

401.36 -1.14

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

397.33

Max

406.51

Schlüsselkennzahlen

By Trading Economics

Einkommen

-491M

693M

Verkäufe

1.2B

41B

KGV

Branchendurchschnitt

36.498

56.659

EPS

7.61

Dividendenrendite

0.92

Gewinnspanne

1.696

Angestellte

67,060

EBITDA

-658M

1.3B

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+7.05% upside

Dividenden

By Acuity

Dividendenrendite

Branchendurchschnitt

0.92%

2.18%

Nächstes Ergebnis

4. Nov. 2026

Nächste Dividendenausschüttung

27. Nov. 2026

Nächstes Ex-Dividendendatum

30. Sept. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-724M

46B

Vorheriger Eröffnungskurs

402.5

Vorheriger Schlusskurs

401.36

Nachrichtenstimmung

By Acuity

26%

74%

58 / 339 Ranking in Healthcare

Humana Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

3. Sept. 2026, 20:07 UTC

News

Humana Inc has earned the 2026 Great Place To Work Certification, contributing to positive investor sentiment as shares advance during Thursday's session.

2. Sept. 2026, 20:08 UTC

News

Humana Inc. shares are advancing as the company declared a quarterly cash dividend of $0.885 per share, payable on November 27, 2026.

1. Sept. 2026, 20:01 UTC

News
Event

Humana Inc. reaffirmed its fiscal year 2026 guidance, projecting at least $9 adjusted EPS, contributing to a positive market reaction and higher shares.

27. Aug. 2026, 19:46 UTC

News

Humana has partnered with DaVita to enhance care for Medicare Advantage members with chronic kidney disease. Shares are advancing amid positive market sentiment.

26. Aug. 2026, 20:08 UTC

Humana Inc shares are higher today amid mixed market performance and inflation data showing a slight consumer price increase in July.

25. Aug. 2026, 22:02 UTC

Humana Inc shares are higher in after-market hours, rebounding from session lows despite a broader market pullback and declining consumer confidence.

24. Aug. 2026, 20:06 UTC

News

Wolfe Research raised Humana's price target to $450, maintaining an Outperform rating. Shares are higher today, reflecting positive sentiment from the upgrade.

21. Aug. 2026, 19:31 UTC

Humana Inc. shares are advancing, reflecting a broader rebound in U.S. stocks amid ongoing economic uncertainties. They pulled back earlier but regained momentum.

20. Aug. 2026, 19:36 UTC

News

Humana Inc. appointed Dr. Shantanu Nundy as Chief Medical Officer, effective August 31. Shares are higher since Wednesday's close amid this leadership change.

19. Aug. 2026, 19:51 UTC

News

Humana Inc. shares are lower, impacted by a significant decline in the Managed Health Care sub-sector. The company continues expanding its home-based care initiative.

18. Aug. 2026, 19:16 UTC

Humana Inc shares are lower amid broader market weakness and rising U.S. Treasury yields, despite an earlier recovery during the session.

14. Aug. 2026, 19:46 UTC

Humana Inc shares are higher today, reflecting a broader positive market trend despite recent negative sentiment following a decline in U.S. retail sales.

12. Aug. 2026, 20:01 UTC

Humana Inc shares are higher during Wednesday's session, continuing an upward trend since Tuesday. The move occurs amid mixed macroeconomic signals and geopolitical tensions.

10. Aug. 2026, 19:16 UTC

News

Humana shares advance as JPMorgan raises price target to $393.

7. Aug. 2026, 20:03 UTC

Humana Inc shares are higher today, continuing strong momentum from recent sessions. No specific company news was identified to explain this price action.

6. Aug. 2026, 23:02 UTC

Humana Inc shares are lower in after-market trading, continuing a decline since Thursday's close and remaining below their 20-day moving average.

5. Aug. 2026, 19:56 UTC

News
Social Media

Morgan Stanley upgraded Humana Inc to Equal-Weight and raised its price target to $370. Shares are gaining amid positive analyst sentiment and service area expansion.

4. Aug. 2026, 20:04 UTC

News

Humana Inc is under investigation by Bronstein, Gewirtz & Grossman, LLC, raising concerns among investors and contributing to a decline in shares.

3. Aug. 2026, 22:26 UTC

Humana Inc. shares are higher in after-market trading, continuing gains since Monday's close, though still below the 20-day moving average.

31. Juli 2026, 19:36 UTC

News

Humana Inc shares are lower today amid broader weakness in the Managed Health Care sector, despite price target increases from TD Cowen and Barclays.

30. Juli 2026, 18:36 UTC

News

Upgrades from Guggenheim, Evercore ISI boost Humana investor sentiment.

29. Juli 2026, 23:06 UTC

Humana Inc shares are trading lower in after-market hours, continuing a decline below the 20-day moving average and near the one-month trading range's lower end.

28. Juli 2026, 23:16 UTC

News
Social Media

Humana shares decline in after-market trading following the end of a Medicare drug subsidy program, which may raise costs for seniors and pressure insurers.

27. Juli 2026, 19:16 UTC

News

Humana Inc. shares are lower as Schubert Jonckheer & Kolbe LLP investigates potential false statements about healthcare costs amid ongoing securities fraud claims.

24. Juli 2026, 19:31 UTC

Humana Inc's shares are lower today amid broader weakness in the Managed Health Care sub-sector, reversing a trend of higher daily closes since Thursday.

22. Juli 2026, 19:26 UTC

Humana Inc. shares are lower today amid notable volatility and a mixed performance in global markets, with U.S. indices generally declining.

20. Juli 2026, 18:46 UTC

Humana Inc's shares are higher today, reflecting a slight increase since Friday's close. The stock is near the upper end of its one-month trading range.

Peer-Vergleich

Kursveränderung

Humana Inc Prognose

Kursziel

By TipRanks

7.05% Vorteil

12-Monats-Prognose

Durchschnitt 429.86 USD  7.05%

Hoch 624 USD

Tief 280 USD

Basierend auf 23 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Humana Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

23 ratings

11

Buy

11

Halten

1

Sell

Stimmung

By Acuity

58 / 339 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Humana Inc

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
help-icon Live chat